Literature DB >> 26435639

Nesfatin-1 and its effects on different systems.

C Ayada1, Ü Toru2, Y Korkut3.   

Abstract

Nesfatin-1 is a peptide secreted by peripheral tissues, central and peripheral nervous system. It is involved in the regulation of energy homeostasis related with food regulation and water intake. Nesfatin-1 can pass through the blood-brain barrier in both directions. It suppresses feeding independently from the leptin pathway and increases insulin secretion from pancreatic beta islet cells. That is why nesfatin-1 has drawn attention as a new therapeutic agent, especially for the treatment of obesity and diabetes mellitus. Its effects on nutrition have been studied in more detail in literature. On the other hand, its effects on other physiological parameters and mechanisms of action still need to be clarified. Synthesizing the research on nesfatin-1 can help us better understand this field. Hippokratia 2015, 19 (1): 4-10.

Entities:  

Keywords:  Human nesfatin-1 protein; L-type calcium channels; anti-obesity agents; appetite depressants; human nucleobinding 2 protein; nerve tissue proteins

Year:  2015        PMID: 26435639      PMCID: PMC4574585     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  52 in total

1.  The effect of Nesfatin-1 on heart L-type Ca²⁺ channel α1c subunit in rats subjected to chronic restraint stress.

Authors:  C Ayada; G Turgut; S Turgut
Journal:  Bratisl Lek Listy       Date:  2015       Impact factor: 1.278

2.  Troglitazone, a ligand of peroxisome proliferator-activated receptor-{gamma}, stabilizes NUCB2 (Nesfatin) mRNA by activating the ERK1/2 pathway: isolation and characterization of the human NUCB2 gene.

Authors:  Masanobu Yamada; Kazuhiko Horiguchi; Ryohei Umezawa; Koshi Hashimoto; Tetsurou Satoh; Atsushi Ozawa; Nobuyuki Shibusawa; Tsuyoshi Monden; Shuichi Okada; Hiroyuki Shimizu; Masatomo Mori
Journal:  Endocrinology       Date:  2010-04-28       Impact factor: 4.736

3.  Identification of nesfatin-1 as a satiety molecule in the hypothalamus.

Authors:  Shinsuke Oh-I; Hiroyuki Shimizu; Tetsurou Satoh; Shuichi Okada; Sachika Adachi; Kinji Inoue; Hiroshi Eguchi; Masanori Yamamoto; Toshihiro Imaki; Koushi Hashimoto; Takafumi Tsuchiya; Tsuyoshi Monden; Kazuhiko Horiguchi; Masanobu Yamada; Masatomo Mori
Journal:  Nature       Date:  2006-10-01       Impact factor: 49.962

4.  Time-dependent changes in the serum levels of prolactin, nesfatin-1 and ghrelin as a marker of epileptic attacks young male patients.

Authors:  Suleyman Aydin; Ersel Dag; Yusuf Ozkan; Ozgur Arslan; Guray Koc; Semai Bek; Serkan Kirbas; Tayfun Kasikci; Dilek Abasli; Zeki Gokcil; Zeki Odabasi; Zekiye Catak
Journal:  Peptides       Date:  2011-04-30       Impact factor: 3.750

Review 5.  Central and peripheral expression and distribution of NUCB2/nesfatin-1.

Authors:  Miriam Goebel-Stengel; Lixin Wang
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome.

Authors:  Peng Shen; Yingying Han; Bo Cai; Yu Wang
Journal:  Sleep Breath       Date:  2014-07-24       Impact factor: 2.816

7.  Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system.

Authors:  Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-27       Impact factor: 3.619

8.  Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain.

Authors:  G Cristina Brailoiu; Siok L Dun; Eugen Brailoiu; Saadet Inan; Jun Yang; Jaw Kang Chang; Nae J Dun
Journal:  Endocrinology       Date:  2007-07-12       Impact factor: 4.736

9.  Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Jean Rivier; Peter Kobelt; Hubert Mönnikes; Nils W G Lambrecht; Yvette Taché
Journal:  Endocrinology       Date:  2009-10-01       Impact factor: 4.736

10.  Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus.

Authors:  Marion S Bonnet; Emilie Pecchi; Jérôme Trouslard; André Jean; Michel Dallaporta; Jean-Denis Troadec
Journal:  J Neuroinflammation       Date:  2009-09-24       Impact factor: 8.322

View more
  34 in total

1.  Nesfatin-1 Improve Spatial Memory Impairment Following Transient Global Cerebral Ischemia/Reperfusion via Inhibiting Microglial and Caspase-3 Activation.

Authors:  Sohaila Erfani; Ali Moghimi; Nahid Aboutaleb; Mehdi Khaksari
Journal:  J Mol Neurosci       Date:  2018-06-28       Impact factor: 3.444

Review 2.  Novel transmitters in brain stem vagal neurocircuitry: new players on the pitch.

Authors:  Mehmet Bülbül; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-29       Impact factor: 4.052

3.  The association of low levels of nesfatin-1 and glucagon-like peptide-1 with oxidative stress in Parkinson's disease.

Authors:  Gülser Karadaban Emir; Yasemin Ünal; Nigar Yılmaz; Kürsad Tosun; Gülnihal Kutlu
Journal:  Neurol Sci       Date:  2019-07-06       Impact factor: 3.307

4.  A Short-Term Paleolithic Dietary Intervention Does Not Alter Adipokines Linked to Adiposity.

Authors:  Rachel M Graff; Kristofer Jennings; Natalie A Davies; Andres E Carrillo; Emily C Lavoy; Edward J Ryan; Melissa M Markofski
Journal:  Int J Exerc Sci       Date:  2021-04-01

5.  Bariatric Surgery-Induced Resolution of Hypertension and Obstructive Sleep Apnea: Impact of Modulation of Body Fat, Ectopic Fat, Autonomic Nervous Activity, Inflammatory and Adipokine Profiles.

Authors:  Audrey Auclair; Laurent Biertho; Simon Marceau; Frédéric-Simon Hould; Simon Biron; Stéfane Lebel; François Julien; Odette Lescelleur; Yves Lacasse; Marie-Eve Piché; Katherine Cianflone; Sebastian Demian Parlee; Kerry Goralski; Julie Martin; Marjorie Bastien; David H St-Pierre; Paul Poirier
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

6.  Leptin, ghrelin, nesfatin-1, and orexin-A plasma levels in girls with premature thelarche.

Authors:  N Almasi; H Y Zengin; N Koç; S A Uçakturk; D İskender Mazman; N Heidarzadeh Rad; M Fisunoglu
Journal:  J Endocrinol Invest       Date:  2022-06-28       Impact factor: 5.467

Review 7.  Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level.

Authors:  Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; José Ramón González-Juanatey; Francisca Lago
Journal:  Endocrine       Date:  2015-12-12       Impact factor: 3.633

8.  The Relationship between Nesfatin-1 Levels and SYNTAX Score in Patients with Non-ST Segment Elevation Myocardial Infarction.

Authors:  Mevlüt Serdar Kuyumcu; Aliye Kuyumcu; Çağrı Yayla; Mustafa Bilal Özbay; Sefa Ünal; Burak Açar; Cemil Nural; Almila Şenat; Gülhan Samur
Journal:  Acta Cardiol Sin       Date:  2018-09       Impact factor: 2.672

9.  Correlation of NUCB2/Nesfatin-1 with Cytokine Levels in Primary Open-Angle Glaucoma.

Authors:  Milena Pahlitzsch; Raphaela Fritsche-Guenther; Inga Pompös; Dominika Pohlmann; Anna-Karina B Maier; Sibylle Winterhalter; Carl Erb; Anne Rübsam
Journal:  Clin Ophthalmol       Date:  2021-06-16

10.  Protective role and molecular mechanism of action of Nesfatin-1 against high glucose-induced inflammation, oxidative stress and apoptosis in retinal epithelial cells.

Authors:  Haiyan Sun; Huahui Zhao; Zhipeng Yan; Xiaokun Liu; Pengfei Yin; Jun Zhang
Journal:  Exp Ther Med       Date:  2021-06-03       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.